Catalyst Wire Dossier Catalyst Wire Dossier

Janumet

sitagliptin/metformin · Merck & Co.
Drug timelines are a Plus or Pro feature.

35 regulatory and trial events tracked for Janumet, covering 2007-03-30 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)

See pricing